Financials
Financial year 2025
IMMUNIS from Eupen, company number BE0883690091, closed financial year 2025 with a result of € 452,174 after tax. For that financial year IMMUNIS recorded a gross margin of € 617,428 and equity of € 6,161. Compared with financial year 2024, the result moved from € 491,183 to € 452,174. The company is profitable. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on May 11, 2026.
€ 6,161
▲ 1% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 452,174
▼ 8% vs 2024
Profit after tax over the fiscal year.
€ 212,730
▲ 27% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 442,000 paid out
98 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
2.5
Average over the fiscal year, from the social balance sheet.
€ 104,578
▲ 10% vs 2024
€ 41,800 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 61,658
▲ 97% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 380,528
▼ 8% vs 2024
€ 34,333 is repaid this year. At this pace the long-term loan is gone in ≈ 11 years.
€ 165,667
▲ € 152,362 vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 53,029
▲ 103% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 491,940 | € 607,854 | € 638,777 | € 617,428 | ▼ 3% |
| Profit after taxes | € 350,805 | € 444,593 | € 491,183 | € 452,174 | ▼ 8% |
| Equity | € 7,898 | € 6,577 | € 6,124 | € 6,161 | ▲ 1% |
| Total debts | € 997,739 | € 980,980 | € 935,776 | € 1,041,223 | ▲ 11% |
| Cash | € 158,885 | € 119,678 | € 168,155 | € 212,730 | ▲ 27% |
| Land & buildings | € 499,972 | € 485,156 | € 470,340 | € 459,172 | ▼ 2% |
| Retained profit | € 121 | € 577 | € 124 | € 161 | ▲ 30% |
| Dividend | € 349,000 | € 434,000 | € 481,500 | € 442,000 | ▼ 8% |
| Bank debt | € 604,361 | € 449,194 | € 414,861 | € 380,528 | ▼ 8% |
| Balance sheet total | € 1,005,638 | € 987,557 | € 941,900 | € 1,047,385 | ▲ 11% |
| Employees (FTE) | 2.5 | 2.1 | 2.5 | 2.5 |
Key figures of IMMUNIS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to IMMUNIS?
What happened at IMMUNIS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 452,174 (▼ 8% vs 2024). Source: NBB ↗
- Summa SRL stepped down as director. NBB
- Consultriks SRL became a director. NBB
- New establishment in Eupen. KBO
- Start of the company according to the CBE. KBO
In short
From € 350,805 profit in 2022 to € 452,174 profit in 2025.
Paid € 10,653 in corporate taxes since 2022.
Best year ever: 2024, with € 491,183 profit.
On average € 247,000 of value added per employee in 2025.
A new publication or filing at IMMUNIS? We notify you, reason included.
Follow IMMUNISDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind IMMUNIS are YS Projects SRL, Schumacher Consulting SRL, Consultriks SRL and Filibra SRL.
Directors
According to the 2025 annual accounts
Director · represented by Yannick Schumacher
Director · represented by Christian Schumacher
Director · represented by Katrin Hendriks
since 2023
Director · represented by Philipp Münster
Director · represented by Roland Seel
· until 2025
Establishments
Establishment units
Physical locations of this company
Kaperberg 7
4700 Eupen
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0883.690.091
- VAT number
- BE 0883.690.091
- Registered office
- Kaperberg 7, 4700 Eupen
- Names & denominations
- IMMUNIS
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 21 September 2006
- Peppol
- Active · Active since 9 Oct 2025
- Activities · NACE
Activiteiten van (gecertificeerde) (fiscaal) accountants
Boekhouders
Boekhouders en boekhouders-fiscalisten
Accountants
Belastingconsulenten
Accountants en belastingconsulenten